AMG-1694 is a potent small molecule disruptor of the GK-GKRP complex with an IC50 of 7 nM. It indirectly activates glucokinase, reverses GKRP-mediated inhibition, and promotes GK translocation. This compound effectively normalizes blood glucose in diabetic rodent models without inducing hypoglycemia in normoglycemic animals, making it a valuable research tool for studying type 2 diabetes pathways.